Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells
- 1 December 2000
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 36 (6) , 1242-1252
- https://doi.org/10.1053/ajkd.2000.19840
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Role of vascular endothelial growth factor in the regulation of angiogenesisKidney International, 1999
- Production of Vascular Endothelial Growth Factor by Murine MacrophagesThe American Journal of Pathology, 1998
- Renal microvascular assembly and repair: Power and promise of molecular definitionKidney International, 1998
- Vascular Endothelial Growth Factor/Vascular Permeability Factor Produces Nitric Oxide–Dependent HypotensionArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.Journal of Clinical Investigation, 1997
- Nitric Oxide: Cytotoxicity versus Cytoprotection— How, Why, When, and Where?Nitric Oxide, 1997
- Nitric Oxide: Pathophysiological MechanismsAnnual Review of Physiology, 1995
- Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factorKidney International, 1993
- Vascular permeability factor mRNA and protein expression in human kidneyKidney International, 1992
- Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene familyBiochemical and Biophysical Research Communications, 1989